Matos Paulo, Jordan Peter
Centro de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, 1649-016 Lisboa, Portugal.
Centro de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, 1649-016 Lisboa, Portugal.
J Biol Chem. 2006 May 12;281(19):13724-13732. doi: 10.1074/jbc.M513243200. Epub 2006 Mar 21.
Increased NF-kappaB-mediated transcription has been extensively linked to tumorigenesis and can be stimulated by deregulated Rac1 signaling. For example, the overexpression of Rac1b, a highly activated splicing variant of Rac1 with increased expression in colorectal tumors, stimulates NF-kappaB-mediated G1/S progression and cell survival, and was shown to promote cell transformation and epithelial-mesenchymal transition. Here we show evidence of further complexity between Rac1b and Rac1 signaling toward NF-kappaB in colorectal cells. Consistent with data from other cell types we demonstrate that both Rac1 and Rac1b stimulate transcriptional activation from reporter genes driven by NF-kappaB motifs or the cyclin D1 promoter in an IkappaBalpha- and reactive oxygen species-dependent manner. However, we found that in colorectal cells Rac1, but not Rac1b, induces nuclear translocation of RelB and p52, activates transcription from a RelB-specific reporter, and can be isolated in a complex with endogenous RelB and its inhibitor NF-kappaB2/p100. In addition, Rac1 colocalizes at the plasma membrane with RelB, p100, and cullin-1, a core subunit of the E3 ubiquitin ligase that marks p100 for proteolytic processing to p52. Interestingly, this Rac1-specific pathway is not mediated via the production of reactive oxygen species. These data provide evidence that both Rac1 and Rac1b activate the canonical RelA-IkappaBalpha pathway, whereas Rac1 further stimulates NF-kappaB by inducing the RelB-NF-kappaB2/p100 pathway. The RelB pathway was reported to down-regulate canonical NF-kappaB activation during the inflammatory response, suggesting that increased levels of Rac1b in colorectal tumors may promote tumorigenesis by stimulating canonical NF-kappaB signaling while circumventing a negative feedback from the RelB pathway.
核因子κB(NF-κB)介导的转录增加与肿瘤发生密切相关,并且可被失调的Rac1信号传导所刺激。例如,Rac1b是Rac1的一种高度活化的剪接变体,在结直肠癌中表达增加,它可刺激NF-κB介导的G1/S期进展和细胞存活,并已证明其可促进细胞转化和上皮-间质转化。在此,我们展示了结直肠细胞中Rac1b与Rac1信号传导至NF-κB之间存在进一步复杂性的证据。与来自其他细胞类型的数据一致,我们证明Rac1和Rac1b均以依赖IκBα和活性氧的方式刺激由NF-κB基序或细胞周期蛋白D1启动子驱动的报告基因的转录激活。然而,我们发现,在结直肠细胞中,Rac1而非Rac1b可诱导RelB和p52的核转位,激活来自RelB特异性报告基因的转录,并且可与内源性RelB及其抑制剂NF-κB2/p100形成复合物。此外,Rac1在质膜上与RelB、p100和cullin-1共定位,cullin-1是E3泛素连接酶的核心亚基,可标记p100以便进行蛋白水解加工成p52。有趣的是,这种Rac1特异性途径并非通过活性氧的产生介导。这些数据提供了证据表明Rac1和Rac1b均激活经典的RelA-IκBα途径,而Rac1通过诱导RelB-NF-κB2/p100途径进一步刺激NF-κB。据报道,RelB途径在炎症反应期间下调经典NF-κB激活,这表明结直肠癌中Rac1b水平升高可能通过刺激经典NF-κB信号传导同时规避RelB途径的负反馈来促进肿瘤发生。